Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase Ib Clinical Investigation of Intraperitoneal Ipilimumab and Nivolumab in Patients With Peritoneal Carcinomatosis Due to Gynecologic Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03508570
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:46.399525+00:00
Published At
2025-05-22T00:00:00+00:00
Record Updated At
2025-05-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Malignant Peritoneal Neoplasm", "Malignant Retroperitoneal Neoplasm", "Metastatic Cervical Carcinoma", "Metastatic Endometrial Carcinoma", "Metastatic Fallopian Tube Carcinoma", "Metastatic Malignant Female Reproductive System Neoplasm", "Metastatic Ovarian Carcinoma", "Metastatic Primary Peritoneal Carcinoma", "Peritoneal Carcinomatosis", "Platinum-Refractory Fallopian Tube Carcinoma", "Platinum-Refractory Malignant Female Reproductive System Neoplasm", "Platinum-Refractory Ovarian Carcinoma", "Platinum-Refractory Primary Peritoneal Carcinoma", "Platinum-Resistant Fallopian Tube Carcinoma", "Platinum-Resistant Malignant Female Reproductive System Neoplasm", "Platinum-Resistant Ovarian Carcinoma", "Platinum-Resistant Primary Peritoneal Carcinoma", "Recurrent Cervical Carcinoma", "Recurrent Endometrial Carcinoma", "Recurrent Fallopian Tube Carcinoma", "Recurrent Malignant Female Reproductive System Neoplasm", "Recurrent Ovarian Carcinoma", "Recurrent Primary Peritoneal Carcinoma", "Stage IV Fallopian Tube Cancer AJCC v8", "Stage IV Ovarian Cancer AJCC v8", "Stage IV Primary Peritoneal Cancer AJCC v8", "Stage IVA Fallopian Tube Cancer AJCC v8", "Stage IVA Ovarian Cancer AJCC v8", "Stage IVA Primary Peritoneal Cancer AJCC v8", "Stage IVB Cervical Cancer AJCC v8", "Stage IVB Fallopian Tube Cancer AJCC v8", "Stage IVB Ovarian Cancer AJCC v8", "Stage IVB Primary Peritoneal Cancer AJCC v8", "Stage IVB Uterine Corpus Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-22"
protocolSection.identificationModule.nctId
"NCT03508570"
protocolSection.identificationModule.officialTitle
"Phase Ib Clinical Investigation of Intraperitoneal Ipilimumab and Nivolumab in Patients With Peritoneal Carcinomatosis Due to Gynecologic Cancers"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Malignant Peritoneal Neoplasm (protocolSection.conditionsModule.conditions)
  • Malignant Retroperitoneal Neoplasm (protocolSection.conditionsModule.conditions)
  • Metastatic Cervical Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Female Reproductive System Neoplasm (protocolSection.conditionsModule.conditions)
  • Metastatic Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Peritoneal Carcinomatosis (protocolSection.conditionsModule.conditions)
  • Platinum-Refractory Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Refractory Malignant Female Reproductive System Neoplasm (protocolSection.conditionsModule.conditions)
  • Platinum-Refractory Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Refractory Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Resistant Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Resistant Malignant Female Reproductive System Neoplasm (protocolSection.conditionsModule.conditions)
  • Platinum-Resistant Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Platinum-Resistant Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Cervical Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Fallopian Tube Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Female Reproductive System Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Cervical Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Fallopian Tube Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Primary Peritoneal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Uterine Corpus Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.